Emergent BioSolutions | EBS - DŁUG





DŁUG Zmiana Data
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Exelixis USD 165.93M 3.61M 2026-06
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Lonza CHF 4.71B 915M 2024-12
Merck USD 49.12B 222M 2026-03
Moderna USD 1.3B 7M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 63.19B 536M 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12